Journals / Türk Patoloji Dergisi / 2016 / Cilt: 32 - Sayı: 2

Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital

Pages
91–98
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Direct immunofluorescence studies help in the majority of cases but further testing such as immunoblotting, immunoelectron microscopy or indirect immunofluorescence becomes essential in cases with overlapping features.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: sub-epidermal bullous disorders belong to immunobullous diseases which develop as a result of autoantibody action against epidermal basement membrane proteins.
📊
Key Findings & Data:This study was undertaken to assess the incidence of various sub-epidermal bullous disorders and the utility of direct immunofluorescence in accurately classifying them, and to study the intensity and pattern of immunofluorescence in various sub-epidermal bullous disorders Material and Method: a 2-year study of 38 cases of sub-epidermal bullous disorders sent for direct immunofluorescence studies formed the study group.
💡
Conclusion & Impact:Direct immunofluorescence studies help in the majority of cases but further testing such as immunoblotting, immunoelectron microscopy or indirect immunofluorescence becomes essential in cases with overlapping features.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: sub-epidermal bullous disorders belong to immunobullous diseases which develop as a result of autoantibody action against epidermal basement membrane proteins. Clinically, they are tense bullae and do not rupture easily. They are classified into various forms based on histopathology and direct immunofluorescence patterns. This study was undertaken to assess the incidence of various sub-epidermal bullous disorders and the utility of direct immunofluorescence in accurately classifying them, and to study the intensity and pattern of immunofluorescence in various sub-epidermal bullous disorders Material and Method: a 2-year study of 38 cases of sub-epidermal bullous disorders sent for direct immunofluorescence studies formed the study group. The specimens were processed as per standard protocols. The clinical details were obtained from case files and requisition sent for histopathological and direct immunofluorescence studies. Results: Thirty-eight patients were diagnosed to have sub-epidermal bullous disorders over the period of 2 years. Twenty five cases of Bullous Pemphigoid, 5 cases of Dermatitis Herpetiformis, 3 cases of linear iga Bullous disorder, 2 cases of Bullous systemic lupus Erythematoses and 1 case each of Epidermolysis Bullosa acquisita, Cicatricial Pemphigoid and Pemphigus gestationis was diagnosed. Positive direct immunofluorescence was seen in 91.3% of the cases. Conclusion: Histopathology alone cannot classify sub-epidermal bullous disorders and direct immunofluorescence studies are mandatory in all of them. Bullous Pemphigoid needs to be distinguished from Epidermolysis Bullosa acquisita which requires salt split direct immunofluorescence studies. Dermatitis Herpetiformis, Bullous systemic lupus Erythematosus and linear iga Bullous disorder show more or less similar histological picture with neutrophilic microabscess. Direct immunofluorescence studies help in the majority of cases but further testing such as immunoblotting, immunoelectron microscopy or indirect immunofluorescence becomes essential in cases with overlapping features.

🔖

Cite This Article

JAIN, S., BASAVARAJ, V., Vimala, M. G. (2022). Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital. Türk Patoloji Dergisi, Cilt: 32 - Sayı: 2, 91–98. https://ajindex.com/articles/640531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bilic M, Mutasim D. Bullous pemphigoid. In: Enna SJ, David BB, editors. xPharm: The Comprehensive Pharmacology Reference. New York, NY: Elsevier Science Inc; 2007.1-9
  2. Esmaili N, Hallaji Z, Soori T, Chams Davatchi C. Bullous Pemphigoid in Iranian patients: A descriptive study on 122 cases. Acta Medica Iranica. 2012;50:335-8
  3. Kulthanan K, Chularojanamontri L, Tuchinda P, Sirikudta W, Pinkaew S. Prevalence and clinical features of Thai patients with bullous pemphigoid. Asian Pac J Allergy Immunol. 2011;29:66- 72
  4. Kroumpouzos G. Specific dermatoses of pregnancy: Advances and controversies. Expert Review Dermatology. 2010;5:633-48
  5. Lu PD, Ralston J, Kamino H, Stein JA. Pemphigoid gestationis. Dermatol Online J. 2010;16:10
  6. Aronson IK, Bond S, Fiedler VC, Vomvouras S, Gruber D, Ruiz C. Pruritic urticarial papules and plaques of pregnancy: Clinical and immunopathologic observations in 57 patients. J Am Acad Dermatol. 1998;39:933-9
  7. Kabir AN, Das RK, Kamal M. Direct immunofluorescence test of skin biopsy samples -result of 204 cases. Dinajpur Med Col J. 2009;2:8-12
  8. Mutasim DF, Adams BB. Immunofluorescence in dermatology. J Am Acad Dermatol. 2001;45:803-22
  9. Alonso-Llamazares J, Gibson LE, Rogers RS 3rd. Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: Review of the Mayo Clinic experience. Int J Dermatol. 2007;46:910-9
  10. Fuertes I, Mascaro JM, Bombi JA, Iranzo P. A retrospective study of clinical, histological and immunological characteristics in patients with dermatitis herpetiformis. The experience of Hospital Clinic De Barcelona, Spain between 1995 and 2010 and a review of literature. Actas Dermosifiliogr. 2011;102:699-705
  11. Lebe B, Nifioglu GG, Seyrek S, Ellidokuz H. Evaluation of clinical and histopathologic/direct immunofluorescence diagnosis in autoimmune vesiculobullous dermatitis: Utility of direct immunofluorescence. Turk Patoloji Derg. 2012;28:11-6 12. Shih PY, Kuo TT, Chiou CC, Wang JR, YU KJ, HO HC. Transition from pemphigus vulgaris to pemphigus foliaceus. Dermatol Sinica. 2009;27:52-8
  12. Feliciani C, Motta A, Castellaneta M, Federica M, De Benedetto A, Toto P, Tulli A. Coexisting pemphigus vulgaris and pemphigus foliaceus in the same patient. Int J Dermatol. 2005;44:139-41
  13. Sousa L, Bajanca R, Cabral J, Fiadeiro T. Dermatitis herpetiformis: Should direct immunofluorescence be the only diagnostic criterion? Pediatr Dermatol. 2002;19:336-9
  14. Inchara YK, Rajalakshmi T. Direct imm